The chemical class known as SVEP1 activators encompasses a diverse array of compounds that can engage with cellular signaling pathways and influence the activity of the human protein SVEP1 (Sushi, Von Willebrand Factor Type A, EGF, and Pentraxin Domain-Containing Protein 1). These chemicals operate within the intricate web of cellular processes, including cell adhesion, inflammation, angiogenesis, and extracellular matrix organization. By modulating specific signaling molecules or enzymes, these activators can elicit a cascade of cellular responses that ultimately lead to the modulation of SVEP1 activity. The actions of these compounds are not limited to a single pathway or mechanism; rather, they can affect various molecular targets such as kinases, integrins, and phosphatases, which in turn can lead to the activation of SVEP1.
The activators within this class can be seen as keys to various cellular locks, influencing signaling pathways at different levels of cellular function. Some of these chemicals directly target enzymes that catalyze critical reactions within signaling cascades, while others bind to receptor sites on cell surfaces, thereby initiating a chain reaction that permeates through the cytoplasm and into the nucleus to affect gene expression. The influence of these activators extends to the modulation of cellular dynamics and architecture, which includes the remodeling of the cytoskeleton and the extracellular matrix. By these means, the activators can indirectly influence the expression, localization, and function of SVEP1, as the protein is implicated in various structural and signaling roles within the cell. It's a complex interplay of activation and regulation, where these chemicals can sway the balance of cellular processes that SVEP1 is part of, thereby modulating its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels, which could possibly activate pathways involving cell adhesion and migration associated with SVEP1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Acts as a tyrosine kinase inhibitor, potentially altering signaling cascades that could possibly activate cell adhesion and migration linked to SVEP1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Serves as a signaling lipid that can modulate endothelial cell responses and angiogenesis, processes in which SVEP1 could possibly be activated. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates inflammatory cytokine production and may influence the inflammatory pathways associated with the pentraxin domain of SVEP1, which could possibly lead to its activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K and can impact downstream AKT signaling, affecting pathways that could possibly activate the activity or expression of SVEP1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, which can impact cell differentiation and function, potentially influencing pathways that could possibly activate SVEP1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibits NF-κB activation and can modulate inflammatory responses where SVEP1 could possibly be activated. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $45.00 | 5 | |
Essential for collagen synthesis, which is important for extracellular matrix organization where SVEP1 could possibly be involved. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Inhibits myosin II and can disrupt cytoskeletal dynamics, which could possibly influence cellular processes and pathways related to SVEP1 activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Inhibits Ras farnesyltransferase, potentially altering cell growth and differentiation pathways that could possibly intersect with SVEP1's functions. | ||||||